Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic overlap between idiopathic pulmonary fibrosis and COVID-19
Richard J. Allen, Beatriz Guillén‐Guío, Emma Croot, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 1, pp. 2103132-2103132
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study
Iain Stewart, Joseph Jacob, Peter M. George, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 6, pp. 693-703
Open Access | Times Cited: 97
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
Sally Singh, Molly M Baldwin, Enya Daynes, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 709-725
Open Access | Times Cited: 80
Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
Filippo Patrucco, Paolo Solidoro, Francesco Gavelli, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 895-895
Open Access | Times Cited: 30
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 2, pp. 77-83
Open Access | Times Cited: 22
Advances in Non-Type 2 Asthma in the Severe Cases: from molecular insights to novel treatment strategies
Tao Liu, Prescott G. Woodruff, Xiaobo Zhou
European Respiratory Journal (2024) Vol. 64, Iss. 2, pp. 2300826-2300826
Closed Access | Times Cited: 9
Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
Juulia Partanen, Paavo Häppölä, Wei Zhou, et al.
Cell Genomics (2022) Vol. 2, Iss. 10, pp. 100181-100181
Open Access | Times Cited: 33
Role of IPF genetic risk loci in post-COVID-19 lung abnormalities: a cohort study
Daniel-Costin Marinescu, Alyson W. Wong, Aditi Shah, et al.
BMJ Open Respiratory Research (2025) Vol. 12, Iss. 1, pp. e002725-e002725
Open Access
Update of Aging Hallmarks in Idiopathic Pulmonary Fibrosis
Ana Lilia Torres-Machorro, Ángeles García-Vicente, Marco Espina-Ordoñez, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 222-222
Open Access
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients
Akinari Tsukada, Daisuke Katagiri, Shinyu Izumi, et al.
Cureus (2025)
Open Access
Alternative splicing in lung influences COVID-19 severity and respiratory diseases
Tomoko Nakanishi, Julian Daniel Sunday Willett, Yossi Farjoun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Severe COVID-19 pneumonia leads to post-COVID-19 lung abnormalities on follow-up CT scans
Takuya Hino, Mizuki Nishino, Vladimir I. Valtchinov, et al.
European Journal of Radiology Open (2023) Vol. 10, pp. 100483-100483
Open Access | Times Cited: 10
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report
Sara C. Auld, Ajay Sheshadri, Jennifer Alexander‐Brett, et al.
Annals of the American Thoracic Society (2024) Vol. 21, Iss. 9, pp. 1219-1237
Closed Access | Times Cited: 3
Viral Infection, Pulmonary Fibrosis, and Long COVID
Hiroto Hatabu, Kenneth M. Kaye, David C. Christiani
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 6, pp. 647-649
Open Access | Times Cited: 15
Recent advances in the genetics of idiopathic pulmonary fibrosis
Paolo Spagnolo, Joyce Lee
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 5, pp. 399-405
Open Access | Times Cited: 8
Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease
Janet Johnston, Delia Dorrian, Dermot Linden, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2238-2238
Open Access | Times Cited: 8
Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases
S Stanel, Pilar Rivera‐Ortega
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Integrative bioinformatics and validation studies reveal KDM6B and its associated molecules as crucial modulators in Idiopathic Pulmonary Fibrosis
Anning Chen, Zhun Sun, Donglin Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Genetic Determinants of the Acute Respiratory Distress Syndrome
Eva Suarez-Pajes, Eva Tosco‐Herrera, Melody Ramirez-Falcon, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3713-3713
Open Access | Times Cited: 5
Integrative analysis reveals the recurrent genetic etiologies in idiopathic pulmonary fibrosis
Shanchun Guo, Yi Dong, Congrong Wang, et al.
QJM (2023) Vol. 116, Iss. 12, pp. 983-992
Closed Access | Times Cited: 5
Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease
Paula Parás‐Bravo, César Fernández‐de‐las‐Peñas, Diego Ferrer‐Pargada, et al.
European Journal of Internal Medicine (2024) Vol. 123, pp. 161-162
Closed Access | Times Cited: 1
Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy
Daisuke Katagiri, Akinari Tsukada, Shinyu Izumi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges
Rudolf K.F. Oliveira, Peter Nyasulu, Adeel Ahmed Iqbal, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Contemporary Concise Review 2022: Interstitial lung disease
D. Smith, Gisli Jenkins
Respirology (2023) Vol. 28, Iss. 7, pp. 627-635
Open Access | Times Cited: 2
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report
Sydney B. Montesi, Christian R. Gómez, Michael F. Beers, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 4, pp. 362-373
Open Access | Times Cited: 2
Pulmonary fibrosis after a new coronavirus infection – versions and controversies: A review
Evgeniy I. Shchepikhin, Е. И. Шмелев, А. Э. Эргешов
Terapevticheskii arkhiv (2024) Vol. 96, Iss. 3, pp. 298-302
Open Access
Page 1 - Next Page

Scroll to top